An Active Pharmaceutical Ingredient (API) is the substance in a medicinal product that produces the intended pharmacological or biological activity. Regulatory frameworks distinguish the API from all other components in a formulation , binders, colourants, preservatives, and so forth , which are classified as excipients and carry no direct pharmacological role. A finished medicine may contain one API or several, depending on its formulation.
Under Australian law, the Therapeutic Goods Administration (TGA) applies API standards through the Therapeutic Goods Act 1989 and the associated Therapeutic Goods (Standard for Active Pharmaceutical Ingredients) Order. Manufacturers and sponsors must demonstrate that an API meets specified identity, purity, and potency requirements before a product containing it can be entered on the Australian Register of Therapeutic Goods (ARTG). The Poisons Standard (the Standard for the Uniform Scheduling of Medicines and Poisons) further classifies individual APIs by their scheduling category, which determines conditions of supply, labelling, and access.
The term is used consistently across international regulatory contexts. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) defines an API in guideline Q7 as "any substance or mixture of substances intended to be used in the manufacture of a drug product and that, when used in the production of a drug, becomes an active ingredient of the drug product." The World Health Organisation employs equivalent terminology in its Good Manufacturing Practices (GMP) guidance for APIs.
In the context of plant-based medicines, cannabinoids, and peptides, identifying the API is a foundational step in regulatory assessment. A botanical extract, for instance, may contain multiple candidate APIs alongside hundreds of other constituents; determining which compound (or combination) is pharmacologically responsible is central to how a product is classified, scheduled, and evaluated for safety and efficacy by the TGA.
Sources:
- Active Pharmaceutical Ingredients , Therapeutic Goods Administration (TGA)
- ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients; International Council for Harmonisation (ICH)
- WHO Good Manufacturing Practices for Active Pharmaceutical Ingredients, World Health Organisation (WHO)